- Home
- NTRB vs DPRO Comparison
NTRB vs DPRO Comparison
Compare NTRB & DPRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NTRB
- DPRO
- Stock Information
- Founded
- NTRB 2016
- DPRO 1998
- Country
- NTRB United States
- DPRO Canada
- Employees
- NTRB N/A
- DPRO N/A
- Industry
- NTRB Industrial Specialties
- DPRO Aerospace
- Sector
- NTRB Health Care
- DPRO Industrials
- Exchange
- NTRB Nasdaq
- DPRO Nasdaq
- Market Cap
- NTRB 71.8M
- DPRO 81.2M
- IPO Year
- NTRB N/A
- DPRO N/A
- Fundamental
- Price
- NTRB $7.15
- DPRO $5.33
- Analyst Decision
- NTRB Buy
- DPRO Strong Buy
- Analyst Count
- NTRB 1
- DPRO 2
- Target Price
- NTRB $13.00
- DPRO $6.50
- AVG Volume (30 Days)
- NTRB 33.0K
- DPRO 1.4M
- Earning Date
- NTRB 09-09-2025
- DPRO 11-13-2025
- Dividend Yield
- NTRB N/A
- DPRO N/A
- EPS Growth
- NTRB N/A
- DPRO N/A
- EPS
- NTRB N/A
- DPRO N/A
- Revenue
- NTRB $2,578,059.00
- DPRO $5,250,872.00
- Revenue This Year
- NTRB $560.75
- DPRO $41.59
- Revenue Next Year
- NTRB $588.39
- DPRO $132.11
- P/E Ratio
- NTRB N/A
- DPRO N/A
- Revenue Growth
- NTRB 42.92
- DPRO 17.08
- 52 Week Low
- NTRB $2.98
- DPRO $1.63
- 52 Week High
- NTRB $9.42
- DPRO $7.31
- Technical
- Relative Strength Index (RSI)
- NTRB 59.09
- DPRO 60.76
- Support Level
- NTRB $5.85
- DPRO $4.28
- Resistance Level
- NTRB $7.48
- DPRO $4.86
- Average True Range (ATR)
- NTRB 0.43
- DPRO 0.34
- MACD
- NTRB 0.12
- DPRO 0.07
- Stochastic Oscillator
- NTRB 80.26
- DPRO 94.92
About NTRB Nutriband Inc.
Nutriband Inc is engaged in the development of a portfolio of transdermal pharmaceutical products. AVERSA technology is the company's product that incorporates aversive agents to prevent the Abuse, Diversion, Misuse, and Accidental exposure of drugs with abuse potential specifically Opioids. The majority of the revenue is generated from the sale of goods that include consumer transdermal and coated products.
About DPRO Draganfly Inc.
Draganfly Inc is a Canada based company. It is engaged in the provision of engineering services and the manufacture of commercial unmanned vehicle systems and software. The company operates in Canada, the United States, and Internationally. The three segments are Drones, Vital (Vital Intelligence), and Corporate. The Drones segment derives its revenue from products and services related to the sale of unmanned aerial vehicles (UAV). The Vital segment derives its revenue from the sale of products that measure vitals to help detect symptoms from large groups of people from a distance. The Corporate segment includes all costs not directly associated with the Drone and Vital segments. It generates majority of its revenue from Drones segment.